Predictors of late complications after coronary artery bypass grafting in patients with stable coronary heart disease

I.V. Shklianka, O.J. Zharinov, К.O. Mikhaliev ,O.A. Yepanchintseva, B.M. Todurov

References 

1. 1.ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography. J. Amer. Soc. Echocardiogr. 2007;20:787-805.

   2.Al Ruzzeh S, Nakamura K, Athanasiou T, Modine T, Shane G, Yacoub  M, Ilsley  C, Amrani M. Does off-pump coronary artery bypass (OPCAB) surgery improve the outcome in high-risk patients? A comparative study of 1398 high-risk patients. Eur. J. Cardiothorac. Surg. 2003;23:50-55. doi.org/10.1016/s1010-7940(02)00654-1. 

   3.Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, Demitriadis DS, Kontopoulos AG. Treatment with atorvastatin to the National cholesterol educational program goal versus "usual" care in secondary coronary heart disease prevention: The GREek Atorvastatin and Coronary-heart-disease Evaluation Study (GREACE). Cur. Med. Res. Opin. 2002;18:220-228. doi.org/10.1185/030079902125000787.

   4.Barner HB. Operative treatment of coronary atherosclerosis. Ann. Thorac. Surg. 2008;85:1473-1482. doi.org/10.1016/j.athoracsur.2008.01.014. 

   5.Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am. J. Kidney Dis. 2009;53:961-973. doi.org/10.1053/j.ajkd.2008.11.034. 

   6.Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 1986;57:450.

   7.Domanski MJ, Borkowf CB, Campeau L, Knatterud GL, White C, Hoogwerf B, Rosenberg Y, Geller NL. Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators. J. Am. Coll. Cardiol. 2000;36:1877-1883. doi.org/10.1016/s0735-1097(00)00973-6 

   8.Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. New Engl. J. Med. 2012;367:2375-2384. doi.org/10.1056/nejmoa1211585. 

   9.Filsoufi F, Jouan J, Chilkwe J, Rahmanian PR, Castillo J, Carpentier AF, Adams DH. Results and predictors of early and late outcome of coronary artery bypass graft surgery in patient with ejection fraction less than 20 %. Arch. Cardiovasc. Dis. 2008;101(9):547-556. doi.org/10.1016/j.acvd.2008.09.008. 

   10.Flynn M, Reddy S, Shepherd W, Holmes C, Armstrong D, Lunn C, Khan K, Kendall S. Fast-tracking revisited: routine cardiac surgical patients need minimal intensive care. Eur. J. Cardiothorac. Surg. 2004;25:116-122. doi.org/10.1016/s1010-7940(03)00608-0. 

   11.Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A. Acute kidney injury is associated with inсreased long-term mortality after cardiothoracic surgery. Circulation. 2009;119:2444-2453. doi.org/10.1161/circulationaha.108.800011. 

   12.Kang S, Liu Y, Liu X.B. Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials. Clin. Ther. 2013;35(8):1125-1136.  doi.org/10.1016/j.clinthera.2013.06.006.

   13.Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a metaanalysis. Circulation. 2005;111(22):2906-2912. doi.org/10.1161/circulationaha.104.521864. 

   14.Kulik A, Brookhart MA, Levin R, Ruel M, Solomon DH, Choudhry NK. Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery. Circulation. 2008;118:1785-1792. doi.org/10.1161/circulationaha.108.799445. 

   15.Lang RM, Badano LP, Mor-Avi V,  Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. JASE. 2015;28(1):1-39. doi.org/10.1016/j.echo.2014.10.003. 

   16.Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB, Iannelli G, Ambrosio G. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium-to high-risk patients: a prospective, randomized study. J. Am. Coll. Cardiol. 2009;54:989-996. doi.org/10.1016/j.jacc.2009.05.041 

   17.Montalescot G, Sechtem U, Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease. The task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 2013;34:2949-3003. doi.org/10.1093/eurheartj/eht296. 

   18.Neumann F-J, Sousa-Uva M, Ahlsson A. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2018;00:1-96. doi:10.1093/eurheartj/ehy394.

   19.Philip F, Blackstone E, Kapadia SR. Impact of statins and beta-blocker therapy on mortality after coronary artery bypass graft surgery. Cardiovasc. Diagn. Ther. 2015;5(1):8-16.

   20.Sahin T, Ural D, Kilic T. et al. Evaluation of left atrial appendaje functions according to different etiologies of atrial fibrillation with a tissue Doppler imaging technique by using transesophageal echocardiography. Echocardiography. 2009;26:171-181. doi.org/10.1111/j.1540-8175.2008.00794.x. 

   21.Soliman Hamad MA, van Straten AHM, Schönbergeret J. et al. Preoperative ejection fraction as a predictor of survival after coronary artery bypass grafting: comparison with a matched general population. Cardiothorac. Surg. 2010;5:29-36. doi.org/10.1186/1749-8090-5-29. 

   22.Tavilla G, Kappetein AP, Braun J. et al. Long-term follow-up of coronary artery bypass grafting in three-vessel disease using exclusively pedicled bilateral internal thoracic and right gastroepiploic arteries. Ann. Thorac. Surg. 2004;77:794-799. doi.org/10.1016/s0003-4975(03)01659-x. 

   23.Thakar C, Worley S, Arrigain S, Yared JP, Paganini E. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int. 2005;67:1112-1119. doi.org/10.1111/j.1523-1755.2005.00177.x. 

   24.Velazquez EJ, Lee KL, Jones RH. et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. New Engl. J. Med. 2016;374:1511-1520. doi.org/10.1056/nejmoa1602001. 

   25.Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the coronary artery bypass graft surgery trialists collaboration. Lancet. 1994;344(8922):563-570. doi.org/10.1016/s0140-6736(94)91963-1.